NASDAQ:BEAM

Beam Therapeutics Stock Predictions

etoro logo Buy BEAM
*Your capital is at risk
$29.55
+0.590 (+2.04%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BEAM Prediction Chart

BEAM Predictions History

Latest community submissions for BEAM.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 11, 2026 $26.13 -3.05% $25.99 V 99.47% 4
Feb 11, 2026 $27.46 +1.91% $25.99 X 94.33% 0
Feb 11, 2026 Bullish $25.99 X 0
May 29, 2025 Bullish $16.32 X 0
Feb 25, 2025 $31.65 +2.80% $29.84 X 93.93% 0
Feb 25, 2025 $31.33 +1.75% $29.84 X 95.01% 0
Feb 25, 2025 Bullish $29.84 X 0
Nov 1, 2023 $20.57 -2.69% $21.04 V 97.78% 1
Nov 1, 2023 $20.79 -1.68% $21.04 V 98.79% 2
TradeRunner TradeRunner Amateur
Nov 1, 2023 $23.00 +20.36% $21.04 V 90.68% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BEAM with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BEAM THERAPEUTICS INC.
Beam Therapeutics
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE